05.26.21 How Takeda Is Expanding Its Real-World Data Through A Global Myeloma Trial
Combining drugs that may have been shelved with established, safe, and approved drugs has the potential to bring safer, effective therapies to patients. Attend this webinar to learn more about key trends, understanding technical challenges, and shortening timelines by smart working in parallel for scale-up and late-phase development. Click here to register.
Featured Editorial
By Dawn Marie Stull, Takeda Oncology
There is more focus than ever before on tailoring treatment plans to the unique needs of patients. One way to ensure that we as an industry are delivering the most value is by examining real-world data (RWD) throughout the drug development process.